Table 5.
Treatment | CD31+ | CD45+ | CD11b+ | F4/80+ | GR‐1+ | CD4+ | CD8+ |
---|---|---|---|---|---|---|---|
PBS | 1074 ± 748 | 7682 ± 3220 | 7002 ± 601 | 2316 ± 186 | 61 ± 63 | 0 | 0 |
FGF2 | 12,228 ± 2024 | 37,467 ± 5900 | 13,469 ± 2372 | 17,401 ± 7187 | 82 ± 115 | 154 ± 169 | 654 ± 834 |
Eight μm frozen sections of Matrigel plugs containing PBS or FGF2 (five plugs per group) were immunostained for the indicated antigens. Then, the corresponding immunoreactive areas were analysed in five microscopic fields per Matrigel section (two sections per Matrigel plug) using the ImagePro Plus software. Analysis was performed on plugs on day 7 after implantation. Data (mean ± SD) are expressed as μm2 of immunoreactive area per microscopic field (0.38 mm2).